Della Corte, C.M.; Fasano, M.; Papaccio, F.; Ciardiello, F.; Morgillo, F.
Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. Biomedicines 2014, 2, 345-358.
https://doi.org/10.3390/biomedicines2040345
AMA Style
Della Corte CM, Fasano M, Papaccio F, Ciardiello F, Morgillo F.
Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. Biomedicines. 2014; 2(4):345-358.
https://doi.org/10.3390/biomedicines2040345
Chicago/Turabian Style
Della Corte, Carminia Maria, Morena Fasano, Federica Papaccio, Fortunato Ciardiello, and Floriana Morgillo.
2014. "Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer" Biomedicines 2, no. 4: 345-358.
https://doi.org/10.3390/biomedicines2040345
APA Style
Della Corte, C. M., Fasano, M., Papaccio, F., Ciardiello, F., & Morgillo, F.
(2014). Role of HGF–MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. Biomedicines, 2(4), 345-358.
https://doi.org/10.3390/biomedicines2040345